サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：創傷ケアの世界市場-2023年～2030年
市場調査レポート
商品コード
1347969

創傷ケアの世界市場-2023年～2030年

Global Wound Care Market - 2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
創傷ケアの世界市場-2023年～2030年
出版日: 2023年09月11日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

創傷ケアの世界市場は、2022年に185億米ドルに達し、2023～2030年の予測期間中にCAGR 4.5%で成長し、2030年には254億米ドルに達すると予測されています。

創傷ケアは、主に褥瘡、糖尿病性足潰瘍、皮膚裂傷、手術創や火傷、その他の一般創傷の治療に重点が置かれています。世界の創傷ケア市場は、製品の上市数や承認数の増加によって牽引されています。さらに、糖尿病性足潰瘍や褥瘡などの慢性創傷の有病率の増加や、交通事故や自然災害などによる外傷の発生件数の増加があります。

北米地域が市場シェアで大きな位置を占めると予想されます。糖尿病性足潰瘍分野が大きな市場シェアを占めています。糖尿病性足潰瘍の管理における製品の承認と、この疾患の有病率の増加が、このセグメントを重要な位置に保持しています。

ダイナミクス

製品上市数の増加が市場成長の原動力となる

製品上市数の増加が市場成長の原動力になると予想されます。例えば、2023年6月13日、エボニック社のJeNaCellは、静脈性下腿潰瘍、動脈性下腿潰瘍、糖尿病性下腿潰瘍、褥瘡、軟部組織病変などの慢性創傷用の創傷被覆材Epicite balanceを発売しました。Epicite balanceには3種類のサイズがあり、Coopmed ApS社を通じて病院や在宅ケアセンターに販売されます。

さらに、2022年10月10日、ベンガルールを拠点とするHealthium Medtech社は、糖尿病性足潰瘍や下腿潰瘍などの慢性創傷管理用の新しい創傷被覆材ポートフォリオTheruptor Novoを発売しました。Theruptor Novoの発売により、ヘルシウムは先進的創傷被覆材分野における特許取得済み製品の既存ポートフォリオを強化しました。このように、製品発売数の増加が市場成長の原動力になると予想されます。

主要企業の戦略が市場成長を牽引すると期待される

買収、提携、パートナーシップなどの戦略が市場成長を強化します。各社の戦略が市場成長を牽引すると期待されます。例えば、2023年5月10日、LifeNet HealthはBioventus Inc.の創傷ケア部門を買収し、TheraSkinなどの画期的な製品を追加して創傷ケアソリューションのポートフォリオを拡大しました。この一歩により、ライフネット・ヘルスは再生医療の世界的リーダーとしての地位を強化し、次世代創傷ケアを提供することになります。

企業の買収もまた、市場の成長を加速させると予想されます。例えば、コロプラストは2023年7月7日、アイスランドの創傷ケア企業であるケレシスを最大13億米ドル（約89億デンマーク・クローネ）で買収することで合意しました。このように、同社の戦略は市場成長を牽引すると予想されます。

創傷ケア製品の高コストが市場成長を制限する

創傷ケア製品のコスト上昇が市場拡大の大きな障害となっています。これは原材料や人件費の高騰によるもので、ドレッシング材、包帯、消毒薬などの創傷ケア用品のコストが上昇しています。高コストの高度な創傷ケア製品は多くの個人には手が出せないため、市場成長の妨げになりかねません。例えば、アクティグラフトは4週間で1,710米ドルから3,780米ドルの製品コストがかかります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 製品上市数の増加
      • 主要企業の戦略
    • 抑制要因
      • 創傷ケア製品の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 高度創傷被覆材
  • 外科用創傷被覆材
  • 従来型創傷被覆材
  • フィルムドレッシング
  • アルギン酸塩ドレッシング
  • ハイドロゲルドレッシング
  • その他

第8章 創傷タイプ別

  • 糖尿病性足潰瘍
  • 褥瘡
  • 手術創・外傷性創傷
  • 静脈性下腿潰瘍
  • 熱傷
  • その他の創傷

第9章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 在宅医療
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Smith & Nephew PLC.
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Molnlycke Health Care Ab
  • Baxter International Inc.
  • Acelity L.P. Inc.
  • Integra Lifesciences Holding Corporation
  • Coloplast A/S
  • Ethicon Inc
  • 3M
  • Medline Industries, LP.
  • Convatec Group.

第13章 付録

目次
Product Code: MD2203

Overview

Global Wound Care Market reached US$ 18.5 billion in 2022 and is expected to reach US$ 25.4 billion by 2030, growing with a CAGR of 4.5% during the forecast period 2023-2030.

Wound care has been focussed mainly on treating pressure ulcers, diabetic foot ulcers, skin tears, surgical wounds and burns, and other general wounds. The global wound care market is being driven by the increased number of launches of the products and their approvals. Additionally, there is an increased prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the rising occurrences of trauma cases, such as those caused by vehicle accidents and natural disasters.

The North America region is expected to hold a significant position in the market share. The diabetic foot ulcers segment holds a significant market share. The approvals of the products in managing the condition and the increase in the prevalence of the disease are holding the segment in a significant position.

Dynamics

Increased Number of Product Launches is Expected to Drive the Market Growth

An increased number of product launches are expected to drive the market growth. For instance, on June 13, 2023, Evonik company JeNaCell launched a wound dressing Epicite balance for chronic wounds, such as venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue lesions. Epicite balance comes in three different sizes and will be distributed through the company Coopmed ApS to hospitals and homecare centers.

Additionally, on 10 October 2022, Bengaluru-based Healthium Medtech launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers. With the launch of Theruptor Novo, Healthium strengthens its existing portfolio of patented products in the advanced wound dressing segment. Thus, an increase in the number of product launches is expected to drive the market growth.

Strategies by the Key Companies are Expected to Drive Market Growth

Strategies such as acquisitions, collaborations, and partnerships strengthen the market growth. The strategies by the companies are expected to drive the market growth. For instance, on May 10, 2023, LifeNet Health expanded its portfolio of wound care solutions, adding revolutionary products such as TheraSkin, with the acquisition of the Bioventus Inc. wound care division. This step strengthens LifeNet Health's position as a global leader in regenerative medicine, offering next-level wound care.

Acquisition of the companies is also expected to accelerate the market growth. For instance, on July 7, 2023, Coloplast came to an agreement to acquire Kerecis, an Icelandic wound care company, for up to $1.3 billion (around DKK 8.9 billion), attracted by the company's assumed growth potential in the United States biologics sector. Thus, the company strategies are expected to drive the market growth.

High Cost of Wound Care Products will Restrict the Market Growth

The rising cost of wound care products is a major hindrance to the market's expansion. This is due to increased raw material and labor prices, which are increasing the cost of wound care items such as dressings, bandages, antiseptics, and other products. High-cost, advanced wound care products cannot be afforded by many individuals, which can hamper the market growth. For instance, ActiGraft had a product cost ranging from $1,710 to $3,780 over 4 weeks.

Segment Analysis

The global wound care market is segmented based on product, wound type, end-user, and region.

Diabetic Foot Ulcers Segment Holds a Significant Position in the Market Share

An increase in the prevalence of diabetic foot ulcers is expected to hold the segment growth. For instance, according to NIH, approximately 18.6 million people worldwide are affected by diabetic foot ulcers each year, including 1.6 million people in the United States. These ulcers precede 80% of lower extremity amputations among people diagnosed with diabetes and are associated with an increased risk of death.

Additionally, diabetic foot ulcers were found in 4.54% of patients newly diagnosed with type 2 diabetes mellitus in India, and the prevalence of DFS at the primary care level in Germany is 2.9%. Thus, these factors are expected to hold the segment growth.

Geographical Penetration

North America Region Holds the Largest Market Share in the Global Wound Care Market

North America is expected to hold a dominant share of the market. The increase in the number of launches is expected to hold the region in a significant position. The presence of major players and an increased number of product launches are expected to drive the region's market share. For instance, on 3 January 2023, Convatec announced the US launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.

Additionally, on July 18, 2023, RedDress Medical launched ActiGraft PRO with G-Code reimbursement status for the US wound Care market. Thus, the high number of approvals and launches of the products is holding the region in a significant position.

Competitive Landscape

The global wound care market is fragmented, with the presence of many local and international players. Smith & Nephew PLC., Molnlycke Health Care Ab, Baxter International Inc., Acelity L.P. Inc., Integra Lifesciences, Holding Corporation, Coloplast A/S, Ethicon Inc, 3 M, Medline Industries, LP., and Convatec Group. are the leading Companies with a significant market share.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global wound care market. COVID-19 pandemic caused disruption in the manufacturing of wound care products. The availability of wound care products has been reduced due to the outbreak of the pandemic.

As the coronavirus rapidly spread, medical attention shifted to treating COVID-affected patients while protecting others from infection. Patients became apprehensive about seeking wound care due to shelter-in-place orders and concerns about contracting the coronavirus. Thus, COVID-19 has impacted the market growth negatively.

Key Developments

  • On MARCH 3, 2023, Bactiguard released a broad range of infection prevention solutions, from a unique coating technology to a portfolio of coated medical devices. The portfolio also includes biocompatible and effective wound care products, which are now launched in the UK and Ireland.

By Product

  • Advanced Wound Dressings
  • Surgical Wound Dressings
  • Traditional Wound Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Others

By Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Surgical & Traumatic Wounds
  • Venous Leg Ulcers
  • Burns
  • Other Wounds

By End-User

  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Why Purchase the Report?

  • To visualize the global wound care market segmentation based on product, wound type, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of wound care market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global wound care market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Wound Type
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased number of product launches
      • 4.1.1.2. Strategies by the key companies
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of wound care products
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Advanced Wound Dressings *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Wound Dressings
  • 7.4. Traditional Wound Dressings
  • 7.5. Film Dressings
  • 7.6. Alginate Dressings
  • 7.7. Hydrogel Dressings
  • 7.8. Others

8. By Wound Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.1.2. Market Attractiveness Index, By Wound Type
  • 8.2. Diabetic Foot Ulcers *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pressure Ulcers
  • 8.4. Surgical & Traumatic Wounds
  • 8.5. Venous Leg Ulcers
  • 8.6. Burns
  • 8.7. Other Wounds

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Home Care Settings
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Smith & Nephew PLC. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Molnlycke Health Care Ab
  • 12.3. Baxter International Inc.
  • 12.4. Acelity L.P. Inc.
  • 12.5. Integra Lifesciences Holding Corporation
  • 12.6. Coloplast A/S
  • 12.7. Ethicon Inc
  • 12.8. 3M
  • 12.9. Medline Industries, LP.
  • 12.10. Convatec Group.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us